DoctorJeff Beckett

Lecturer and Teaching-Intensive Scholars in Bioscience

Health Sciences

  • Lecturer and Teaching-Intensive Scholars in Bioscience
    Health Sciences
  • +61 3 6324 3995 (Fax)
  • +61 3 6324 5479 (Work)
  • School of Health Science, The Shed, Inveresk, Launceston, Tasmania, 7250

RESEARCH SUMMARy

Jeff's research interests include understanding issues in the area of nutrition and chronic disease (including cardiovascular and respiratory disease, diabetes and obesity) that affect the overall health of the Tasmanian population, but which are also pertinent in other populations.

Expertise

Conducting clinical trials and population-based studies
Nutritional interventions in cardiovascular disease and diabetes
Medical laboratory based research

Current projects

Synbiotics for chemotherapy-related symptom control in solid tumours

FUNDED PROJECTS

  • CONSULTANCY/CONTRACT RESEARCH
    The Efficacy of Synbiotics for Alleviation of Chemotherapy Symptoms in Patients with Solid Tumours: A randomised-crossover, single-group, double-blinded, placebo-controlled clinical trial
    1 Jan 2022 - 31 Dec 2025
    People funded by this grant:
    • Beckett J,
    • Eri R
    Project Total: $29,970; Cancer is the leading cause of mortality in Australia and is expected to account for around 50,000 deaths in 2021. Most cancer patients undergo chemotherapy treatment; however, it is associated with many complications including widespread mucositis (painful inflammation and ulcer), manifesting as pain, inflammation, bleeding, risk of infections and diarrhoea. The severity of chemotherapy induced symptoms commonly leads to complete cessation of chemotherapy, compromising the patient's cancer treatment. Prebiotic fibre and probiotics have, individually, demonstrated a tremendous potential in the treatment of gut complications. Recent preclinical studies in our laboratory using synbiotics (a combination of prebiotics and probiotics) have provided exciting evidence of their anti-inflammatory and mucosal healing effects. Such promising results have prompted us to investigate the potential benefit of synbiotics in patients receiving chemotherapy. Funded by: Health Food Symmetry Pty Ltd ($29,970); University of Tasmania.
  • GRANT
    Prevalence of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS) in north-west Tasmanian population: understanding and translation to early therapy
    1 Jan 2019 - 31 Dec 2022
    People funded by this grant:
    • Sohal S,
    • Frandsen M,
    • Ahuja K,
    • Beckett J,
    • Mabeza F
    Project Total: $105,868; Asthma and COPD are typically characterised as separate diseases with different clinical features, pathophysiological mechanisms and strategies for treatment. Some respiratory patients appear to have features of both diseases, i.e. a history of asthma and usually smoking, with marked fixed airflow obstruction, which is termed asthma-chronic obstructive pulmonary disease overlap syndrome? (ACOS). Exacerbation rates are also quite high in ACOS patients compared to asthma or COPD alone. There is very little known about the disease and it is difficult to manage clinically because the underlying disease mechanisms and prevalence is poorly understood. There is high prevalence of undiagnosed asthma, COPD and even more for ACOS in the North-West (NW) Tasmanian population, where smoking rates are quite high. People from the low socio-economic population in particular experience considerably greater mortality and morbidity from such respiratory diseases compared to rest of the community. Respiratory lung function lab has now been established in the NW for identification of lung diseases. We now wish to apply for funding with an objective to identify the burden of ACOS in the NW population to inform clinical practice for better management of this ill-understood condition. Funded by: Clifford Craig Foundation - Grant ($105,868); University of Tasmania.